33 related articles for article (PubMed ID: 3484437)
1. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.
Biró E; Nieuwland R; Tak PP; Pronk LM; Schaap MC; Sturk A; Hack CE
Ann Rheum Dis; 2007 Aug; 66(8):1085-92. PubMed ID: 17261534
[TBL] [Abstract][Full Text] [Related]
2. Clinical importance of circulating immune complexes in human acute lymphoblastic leukemia.
Croce MV; Fejes M; Riera N; Minoldo DA; Segal-Eiras A
Cancer Immunol Immunother; 1985; 20(1):91-5. PubMed ID: 3877563
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of circulating immune complexes in lymphomas and leukemias using two different assays.
Patel GV; Gopal R; Nadkarni JJ
Cancer Immunol Immunother; 1985; 20(1):80-4. PubMed ID: 3877562
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexes in malignant diseases increased detection rate by simultaneous use of three assay methods.
Krapf F; Renger D; Schedel I; Fricke M; Kemper A; Deicher H
Cancer Immunol Immunother; 1983; 15(2):138-43. PubMed ID: 6603263
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the classical and lectin pathway of the complement system by recombinant LAIR-2.
Olde Nordkamp MJ; Boross P; Yildiz C; Jansen JH; Leusen JH; Wouters D; Urbanus RT; Hack CE; Meyaard L
J Innate Immun; 2014; 6(3):284-92. PubMed ID: 24192271
[TBL] [Abstract][Full Text] [Related]
6. Specific detection of antibodies to different flaviviruses using a new immune complex ELISA.
Schmitz H; Gabriel M; Emmerich P
Med Microbiol Immunol; 2011 Nov; 200(4):233-9. PubMed ID: 21533786
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against C1q: view on clinical relevance and pathogenic role.
Siegert CE; Kazatchkine MD; Sjöholm A; Würzner R; Loos M; Daha MR
Clin Exp Immunol; 1999 Apr; 116(1):4-8. PubMed ID: 10209498
[No Abstract] [Full Text] [Related]
8. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus.
Siegert CE; Daha MR; Tseng CM; Coremans IE; van Es LA; Breedveld FC
Ann Rheum Dis; 1993 Dec; 52(12):851-6. PubMed ID: 8311534
[TBL] [Abstract][Full Text] [Related]
9. Formation of C3-IgG complexes in serum by aggregated IgG and by non-immunoglobulin activators of complement.
van Dam AP; Hack CE
Immunology; 1987 Jun; 61(2):105-10. PubMed ID: 3596635
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.
Uwatoko S; Mannik M
J Clin Invest; 1988 Sep; 82(3):816-24. PubMed ID: 3262124
[TBL] [Abstract][Full Text] [Related]
11. [Autoantibodies against the complement component C1q in systemic lupus erythematosus].
Antes U; Heinz HP; Hartung K; Loos M
Klin Wochenschr; 1990 Nov; 68(21):1066-70. PubMed ID: 2084321
[TBL] [Abstract][Full Text] [Related]
12. C1q-bearing immune complexes detected by a monoclonal antibody to human C1q in rheumatoid arthritis sera and synovial fluids.
Antes U; Heinz HP; Schultz D; Brackertz D; Loos M
Rheumatol Int; 1991; 10(6):245-50. PubMed ID: 2041983
[TBL] [Abstract][Full Text] [Related]
13. Detection of DNA-bound immunoglobulins in patients with lupus nephritis, using monoclonal anti-DNA antibody.
Koyama A; Kobayashi M; Suzuki S; Suzuki M; Yamaguchi N; Narita M
Clin Exp Immunol; 1991 Aug; 85(2):246-53. PubMed ID: 1864004
[TBL] [Abstract][Full Text] [Related]
14. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
Hack CE; Belmer AJ
Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
[TBL] [Abstract][Full Text] [Related]
15. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
Antes U; Heinz HP; Loos M
J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
[TBL] [Abstract][Full Text] [Related]
16. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
Larsson A; Sjöquist J
J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
18. [Current situation and problems in the estimation of circulating immune complexes].
Yoshida H
Rinsho Byori; 1992 Jan; 40(1):28-33. PubMed ID: 1545522
[TBL] [Abstract][Full Text] [Related]
19. Pitfalls in the methodology for detection of immune complexes.
Heimer R; Per S
Surv Immunol Res; 1982; 1(1):109-16. PubMed ID: 6195708
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
